Form EFFECT CITIUS ONCOLOGY, INC.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 4, 2025 4:15 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MindWave Innovations Inc. (NYSE American: APUS) Builds Institutional Bridge for Bitcoin Treasury Adoption
- VERAXA Biotech AG (NASDAQ: VRXA) Is ‘One to Watch’
- Atropos Health Expands Partnership with Databricks with the Launch of the Atropos Evidence Agent MCP on Databricks Marketplace
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share